Spots Global Cancer Trial Database for needle biopsy
Every month we try and update this database with for needle biopsy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment | NCT00673569 | Lung Cancer | erlotinib hydro... gene expression... protein express... immunoenzyme te... immunologic tec... laboratory biom... needle biopsy | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Laser Spectroscopy of Breast Tissue Through a Needle Device | NCT00918788 | Breast Cancer | biologic sample... immunohistochem... light microscop... medical chart r... histopathologic... needle biopsy spectroscopy | - | Case Comprehensive Cancer Center | |
| Endobronchial Ultrasound Versus Mediastinoscopy in Patients With Non-Small Cell Lung Cancer (NSCLC) | NCT00559611 | Lung Cancer | Endobronchial U... Mediastinoscopy | 18 Years - | M.D. Anderson Cancer Center | |
| Ultrasound-Guided Needle Biopsy in the Diagnosis of Malignant Cervical Lymphadenopathies | NCT01384357 | Lymphadenopathy Malignancy | 20 Years - 85 Years | Far Eastern Memorial Hospital | ||
| Endobronchial Ultrasound Versus Mediastinoscopy in Patients With Non-Small Cell Lung Cancer (NSCLC) | NCT00559611 | Lung Cancer | Endobronchial U... Mediastinoscopy | 18 Years - | M.D. Anderson Cancer Center | |
| PET Scans in Assessing Response To Treatment in Patients Receiving Hormone Therapy or Trastuzumab for Breast Cancer | NCT00362973 | Breast Cancer | laboratory biom... needle biopsy positron emissi... radionuclide im... fludeoxyglucose... | 18 Years - 120 Years | University of Washington | |
| Comparison Of Effectiveness of Transrectal Ultrasonography-Guided Saturation Biopsy And 10-12 Core Biopsy In Repeated Prostate Biopsies | NCT01827813 | Prostate Cancer | Transrectal pro... Periprostatic b... Sedoanalgesia | 40 Years - 70 Years | TC Erciyes University | |
| Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules | NCT05229341 | Thyroid Gland C... | Diagnostic Proc... Electronic Heal... Needle Biopsy | 18 Years - | City of Hope Medical Center | |
| Comparison Of Effectiveness of Transrectal Ultrasonography-Guided Saturation Biopsy And 10-12 Core Biopsy In Repeated Prostate Biopsies | NCT01827813 | Prostate Cancer | Transrectal pro... Periprostatic b... Sedoanalgesia | 40 Years - 70 Years | TC Erciyes University | |
| Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer | NCT01259089 | Adenocarcinoma ... Non-small Cell ... | erlotinib hydro... Hsp90 inhibitor... laboratory biom... needle biopsy mutation analys... pharmacological... | 18 Years - | Northwestern University | |
| Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery | NCT00665457 | Breast Cancer | filgrastim capecitabine celecoxib cyclophosphamid... docetaxel doxorubicin hyd... gene expression... polymorphism an... protein express... reverse transcr... imaging biomark... immunohistochem... laboratory biom... pharmacogenomic... dynamic contras... needle biopsy neoadjuvant the... radiomammograph... ultrasound imag... | 19 Years - 120 Years | University of Nebraska | |
| Ultrasound-Guided Needle Biopsy in the Diagnosis of Malignant Cervical Lymphadenopathies | NCT01384357 | Lymphadenopathy Malignancy | 20 Years - 85 Years | Far Eastern Memorial Hospital | ||
| C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer | NCT00804245 | Prostate Cancer | needle biopsy PET-CT scans su... | 30 Years - 120 Years | Wake Forest University Health Sciences | |
| Correlation of X-ray and Pathology With Needle Biopsy of Lung Tumors | NCT00638625 | Lung Neoplasm | 18 Years - | State University of New York - Upstate Medical University | ||
| Laboratory Test in Predicting Response to Erlotinib in Patients With Relapsed Metastatic or Unresectable Non-Small Cell Lung Cancer That Did Not Respond to Previous Treatment | NCT00673569 | Lung Cancer | erlotinib hydro... gene expression... protein express... immunoenzyme te... immunologic tec... laboratory biom... needle biopsy | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules | NCT05229341 | Thyroid Gland C... | Diagnostic Proc... Electronic Heal... Needle Biopsy | 18 Years - | City of Hope Medical Center | |
| Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations | NCT00700778 | BRCA1 Mutation Breast Cancer | recombinant hum... microarray anal... immunohistochem... laboratory biom... needle biopsy | 20 Years - 40 Years | Fox Chase Cancer Center | |
| Correlation of X-ray and Pathology With Needle Biopsy of Lung Tumors | NCT00638625 | Lung Neoplasm | 18 Years - | State University of New York - Upstate Medical University | ||
| Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules | NCT00316823 | Head and Neck C... | gene expression... polymerase chai... reverse transcr... diagnostic labo... immunohistochem... needle biopsy | 18 Years - | National Cancer Institute (NCI) | |
| Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer | NCT01259089 | Adenocarcinoma ... Non-small Cell ... | erlotinib hydro... Hsp90 inhibitor... laboratory biom... needle biopsy mutation analys... pharmacological... | 18 Years - | Northwestern University | |
| Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery | NCT00665457 | Breast Cancer | filgrastim capecitabine celecoxib cyclophosphamid... docetaxel doxorubicin hyd... gene expression... polymorphism an... protein express... reverse transcr... imaging biomark... immunohistochem... laboratory biom... pharmacogenomic... dynamic contras... needle biopsy neoadjuvant the... radiomammograph... ultrasound imag... | 19 Years - 120 Years | University of Nebraska | |
| Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations | NCT00700778 | BRCA1 Mutation Breast Cancer | recombinant hum... microarray anal... immunohistochem... laboratory biom... needle biopsy | 20 Years - 40 Years | Fox Chase Cancer Center | |
| False/Negative Rate of Lung Percutaneous Needle Biopsy | NCT00638352 | Lung Neoplasm | 18 Years - | State University of New York - Upstate Medical University | ||
| Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules | NCT00316823 | Head and Neck C... | gene expression... polymerase chai... reverse transcr... diagnostic labo... immunohistochem... needle biopsy | 18 Years - | National Cancer Institute (NCI) | |
| Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease | NCT00813878 | Breast Cancer | protein analysi... protein express... proteomic profi... diagnostic labo... immunohistochem... liquid chromato... mass spectromet... fine-needle asp... needle biopsy radiomammograph... | 18 Years - 120 Years | City of Hope Medical Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
